Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 718 clinical trials in Bilthoven, The Netherlands across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma
The NetherlandsStudy on Dapagliflozin for Patients with Severe Chronic Kidney Disease to Improve Kidney and Heart Health Outcomes
The NetherlandsStudy of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure
The NetherlandsStudy of Bosutinib for Children with Newly Diagnosed or Resistant Chronic Myeloid Leukemia
The NetherlandsStudy on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia
The NetherlandsStudy on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines
The NetherlandsStudy of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease
The NetherlandsStudy of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
The NetherlandsStudy of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma
The NetherlandsStudy Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments
The NetherlandsStudy Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases
The NetherlandsStudy on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Research focusing on optimizing vaccine effectiveness against multiple infectious diseases, including studies on meningococcal disease and influenza in different age groups.
Novel approaches include investigating optimal vaccination timing and early immunization strategies for enhanced protection.
Advanced studies in breast cancer treatment, examining innovative therapeutic combinations for hormone receptor-positive cases.
Investigations focus on optimizing treatment sequences to improve progression-free survival rates.
Clinical research examining surgical treatments combined with antibiotic therapy for improved patient outcomes.
Studies aim to enhance surgical outcomes through innovative combination therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
